MK

Michael Kowarik

GS Glaxosmithkline Biologicals Sa: 6 patents #2 of 92Top 3%
Johnson & Johnson: 3 patents #45 of 755Top 6%
EZ Eidgenössische Technische Hochschule Zürich: 1 patents #1 of 9Top 15%
Overall (2022): #15,752 of 548,613Top 3%
7
Patents 2022

Issued Patents 2022

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11491220 Methods of producing bioconjugates of E. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof Jeroen GEURTSEN, Pieter Jan BURGHOUT, Eveline Marleen Weerdenburg, Jan Poolman, Kellen Cristhina FAE +7 more 2022-11-08
11484582 Methods and compositions for immune protection against extra-intestinal pathogenic E. coli Jan Poolman, Bert Jacquemyn, Darren Robert ABBANAT, Patricia Ibarra Yon, Peter Wilhelmus Maria Hermans +5 more 2022-11-01
11446370 Bioconjugates of E. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof Jeroen GEURTSEN, Jan Poolman, Kellen Cristhina FAE, Pieter Jan BURGHOUT, Eveline Marleen Weerdenburg +7 more 2022-09-20
11406696 P aeruginosa PcrV-linked antigen vaccines Christiane Feron, Stefan Jochen KEMMLER, Julien Laurent QUEBATTE 2022-08-09
11376314 Immunogenic composition Amirreza Faridmoayer, Rainer Follador, Stefan Jochen KEMMLER, Gerald Johann POSCH, Fabio SERVENTI 2022-07-05
11236136 Methods of producing glycosylated proteins Michael Wetter, Amirreza Faridmoayer, Manuela Mally, Christian A. Lizak, Markus Aebi +3 more 2022-02-01
11220676 Methods of host cell modification Michael Wacker, Fabiana Fernandez 2022-01-11